Evidence map›Paper›PMID 34405475›Full record

ArticleThe American journal on addictions2021

Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID-19 pandemic.

Dawn E Sugarman, Alisa B Busch, R Kathryn McHugh, Olivera J Bogunovic, Catherine D Trinh, Roger D Weiss, Shelly F Greenfield

Open access · bronzeAbstract read
In one paragraph

Article in The American journal on addictions, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Content analysis of perceptions of combined pharmacobehavioral treatment for American Indian people with opioid use disorder.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Dawn E SugarmanDivision of Alcohol, Drugs, and Addiction, McLean Hospital, Belmont, Massachusetts, USA.ORCID 0000-0002-8390-4755
Alisa B BuschDivision of Alcohol, Drugs, and Addiction, McLean Hospital, Belmont, Massachusetts, USA.
R Kathryn McHughDivision of Alcohol, Drugs, and Addiction, McLean Hospital, Belmont, Massachusetts, USA.ORCID 0000-0002-3011-8697
Olivera J BogunovicDivision of Alcohol, Drugs, and Addiction, McLean Hospital, Belmont, Massachusetts, USA.
Catherine D TrinhDivision of Alcohol, Drugs, and Addiction, McLean Hospital, Belmont, Massachusetts, USA.
Roger D WeissDivision of Alcohol, Drugs, and Addiction, McLean Hospital, Belmont, Massachusetts, USA.
Shelly F GreenfieldDivision of Alcohol, Drugs, and Addiction, McLean Hospital, Belmont, Massachusetts, USA.ORCID 0000-0002-9387-1416
Harvard University · USMcLean Hospital · US

Funding

Telemedicine for Treatment of Opioid Use Disorder: NIDA Summer Research Internship ProgramR01DA048533 · NIDA · HARVARD MEDICAL SCHOOL · PI Haiden A Huskamp, Ateev Mehrotra · 2019 to 2026
$5.6M
Increasing Women's Engagement in Medication Treatment for Opioid Use Disorder through Digital InterventionK23DA050780 · NIDA · MCLEAN HOSPITAL · PI SUGARMAN, DAWN E · 2020 to 2024
$938k
Charles Engelhard FoundationNIDA NIH HHS K23 DA050780NIDA NIH HHS K23DA050780NIDA NIH HHS R01 DA048533NIDA NIH HHS R01DA048533
6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe rapid scale-up of telehealth services for substance use disorders (SUDs) during the COVID-19 pandemic presented a unique opportunity to investigate patient experiences with telehealth. This study examined patient perceptions of telehealth in an outpatient SUD treatment program offering individual therapy, group therapy, and medication management.

methodsTwo hundred and seventy adults receiving SUD outpatient treatment were eligible to complete a 23-item online survey distributed by clinicians; 58 patients completed/partially completed the survey. Data were summarized with descriptive statistics.

resultsParticipants were predominately male, White, and well-educated. The majority (86.2%) were "very satisfied" or "satisfied" with the quality of telehealth care. "Very satisfied" ratings were highest for individual therapy (90%), followed by medication management (75%) and group therapy (58%). Top reasons for liking telehealth included the ability to do it from home (90%) and not needing to spend time commuting (83%). Top reasons for disliking telehealth were not connecting as well with other members in group therapy (28%) and the ability for telehealth to be interrupted at home or work (26%). DISCUSSION AND

conclusionsTelehealth visits were a satisfactory treatment modality for most respondents receiving outpatient SUD care, especially those engaging in individual therapy. Challenges remain for telehealth group therapy. SCIENTIFIC SIGNIFICANCE: This is the first study examining patients' perceptions of telehealth for outpatient SUD treatment during the COVID-19 pandemic by treatment service type. Importantly, while many participants found telehealth more accessible than in-person treatment, there was variability with respect to the preferred mode of treatment delivery.

Indexed as

Ambulatory CareCOVID-19OutpatientsPandemicsPatient SatisfactionSubstance-Related DisordersTelemedicineAdultFemaleHealth Care SurveysHumansMalePsychotherapy, Group

Identifiers

PMID34405475
PMCPMC8429128
OpenAlexW3194709447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.